Drug "second bargaining" disputes release more and more loosening signals?

Source: in addition to the dispute on June 4, 2015, China Economic Net noted that recently there has been a "second bargaining" in Chongqing, Jiangsu, Baotou and other places Among them, Baotou evening news also reported the implementation of "second price negotiation" in Qingshan District with "second price negotiation makes drug prices more" grounded " Shi lichen, director of Beijing Dingchen pharmaceutical consulting, told China economic net that under the background of implementing the autonomy of public hospitals in the guidance of the general office of the State Council on the pilot comprehensive reform of urban public hospitals, the "second bargaining" will be the general trend in the future In the 27th China Pharmaceutical Industry Development Summit Forum this year, leaders of many enterprises and associations once again challenged the centralized bidding system, demanding that the unified bidding system for drugs be cancelled as soon as possible, and the bargaining procurement conducted by the buyer and the seller and supervised by the government should be established Yu Mingde, President of China Pharmaceutical Enterprise Management Association, said: "if we can really establish a procurement system led by the buyer and the seller, I support the second bargaining!" behind this statement, Yu Mingde also supported the second bargaining Set up a clear premise: to really establish a bidding and purchasing mechanism led by drug producers and drug users, to realize the market economy of drug circulation, to survive the fittest by the market, the government departments to give full play to the regulatory function, and to improve relevant laws and regulations, rather than acting as a leader There are also many opponents to the "second bargaining" of drugs Some experts pointed out that under the current situation of the pharmaceutical industry, government supervision is essential, and the centralized recruitment system led by the government will inevitably improve in the future, so as to meet the market demand, we must also see the determination of the government to carry out the reform, and the reform of the centralized recruitment system is not a one-day success, we must be patient Some insiders told China economic net that, in fact, China's attitude towards "second bargaining" has been relatively vague and controversial The reporter of China economic network noted that in the No 7 document released at the beginning of this year, it was proposed that "pilot cities of public hospital reform are allowed to purchase drugs by themselves on the provincial drug centralized purchase platform with the city as the unit", which leaves enough room for the second negotiation; At the end of April, Sun Yang, deputy director of the Department of policy and essential drug system of the national health and Family Planning Commission, publicly expressed his firm opposition to the second bargaining; In May, the general office of the State Council issued the guidance on the pilot comprehensive reform of urban public hospitals In terms of the provisions on reducing the cost of drugs and medical consumables, it also pointed to supporting the second bargaining, and predicted that 66 pilot cities of medical reform determined this time would face the second bargaining based on the city It is reported that the second price negotiation of drugs refers to the "second negotiation" between medical institutions and suppliers on the basis of the price determined by the provincial bidding during the actual purchase, so as to reduce the actual purchase price through the "second price negotiation" It is worth noting that no matter the second price negotiation based on the provincial standard or the direct profit transfer to the medical institutions, the second price negotiation has put a lot of pressure on many pharmaceutical enterprises Shi lichen told China economic net that "second bargaining" is equivalent to price reduction, which means that the profits of pharmaceutical enterprises are further compressed, and the pressure of enterprises to cut costs is great In addition, schlichen said, "second bargaining" means that the bidding and procurement system has been elevated to some extent, enterprises need to spend more energy on negotiations with hospitals or medical consortia, and their past price system is also vulnerable to impact The second negotiation also means that some high priced patent drugs and exclusive varieties are in danger of price reduction Recently, at the 2015 group reception day for investors of Listed Companies in Yunnan Province held by panorama.com, Wu Wei, financial director and Secretary of the board of directors of Yunnan Baiyao, said that the company kept reducing costs through large-scale production and procurement advantages, the sales of OTC in exclusive products of Baiyao series accounted for a large proportion, and exclusive varieties and patent products faced second bargaining There are many rumours that the dispute of "second bargaining" deregulation is a dispute In recent years, there have been many rumors of "second bargaining" deregulation On May 21, 2015, Baotou Evening News reported that "the second price negotiation makes the drug price more" grounded "The reporter learned from the health and Family Planning Bureau of Qingshan District, Baotou city that since the country first transferred the purchase right of low-cost drugs commonly used at the grass-roots level to the primary medical institutions of Qixian District, the health and Family Planning Bureau of Qingshan District and the primary medical institutions were" organized "in the first round On the basis of the successful bargaining, the price of 52 kinds of drugs was cut down again recently According to reports, through the efforts of the Department of health and family planning of the autonomous region, the price negotiation work has eliminated the intermediate distribution enterprises and allowed the primary medical institutions and drug manufacturers to directly negotiate prices Relevant leaders of the Bureau of health and family planning of Qingshan District said: "excessively inflated prices have been cut down at the time of the first negotiation This time, the price cut is basically" a struggle for a share of the gross " The lowest cut only a few cents, and the highest cut a few dollars For example, penicillin V potassium, the initial price is 13.9 yuan / box, the first price is reduced to 8 yuan / box, and the second price is reduced to 5 yuan / box " Chongqing, which experienced the "medical reform event" not long ago, seems to have taken action Forenoon, according to the official account of the media, "Chongqing has launched two bargaining prices They have just received a notice from the Wansheng hospital union of Chongqing, which requires that the essential drugs should be given no less than 20%, and the non essential drugs will be given no less than 25% They will consider changing the brand if they do not give up the profits, and the margin will be passed through the commercial company on the morning of May 29th 11 Report to Wansheng consortium before According to the news, Chongqing is devoting the authority of the second bargaining to the health and family planning committees of all districts and counties The progress of each district and county is different Most districts and counties are waiting and still executing according to the listing price of the drug exchange (the lowest transaction price in the early stage) " Coincidentally, the draft for drug centralized procurement in Jiangsu has also been circulated in the industry, and the official account of WeChat has published the full text It is reported that from the perspective of the draft, classified procurement is the key word of the drug procurement in Jiangsu Province In addition, the determination of the bid price is to directly form a consortium with the municipal level as the unit to negotiate the classified price with the pharmaceutical enterprises However, the above rumors in Chongqing, Jiangsu and other places have not yet been confirmed by relevant local agencies In fact, earlier, October 2014 In June, Hubei Province issued a regulation allowing medical institutions above the second level to negotiate with pharmaceutical enterprises for purchase in the way of volume purchase, which means that medical institutions above the second level can directly negotiate with pharmaceutical enterprises on the purchase varieties, specifications, quantities and prices on the basis of centralized bidding at the provincial level, thus breaking the long-term drug negotiations at the provincial level“ Centralized bidding procurement, no second bargaining "of the firm ice Following the opening of the second bargaining in Hubei Province, Tianjin and Hainan are also preparing plans to allow hospitals to negotiate again from 2015 Gansu Provincial Health and Family Planning Commission has also formulated a work plan for price negotiation and online purchase of commonly used low-cost drugs, which makes it clear that medical institutions at all levels can form a "price negotiation Consortium" to realize centralized price negotiation and online purchase of commonly used low-cost drugs Shi lichen told China economic network: "the guiding opinions of the general office of the State Council on the pilot comprehensive reform of urban public hospitals" clearly put forward "to implement the autonomy of public hospitals Improve the corporate governance structure and mechanism of public hospitals, and implement the autonomy of personnel management, internal distribution, operation management, etc of public hospitals, which determines that in the future, hospitals will have more autonomy in drug price issues, "second bargaining" will be the general trend In addition, industry insiders said that the document "guidance on centralized drug procurement in public hospitals" issued by the State Council this year implied that pilot cities of medical reform could try to negotiate twice At present, there are still a few pilot cities to negotiate twice However, in the case of profit-seeking and monopolistic markets in hospitals, the second bargaining may continue to spread.